Skip to main content

Table 1 Oral glucose tolerance test blood glucose values

From: Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model

Blood glucose (mg/dl)

Group

Dose (mg/kg)

T0

T30

T60

T90

T120

Vehicle (-alloxan)

0

91.9 ± 4.9

125.2 ± 5.3

114.3 ± 6.4

93.4 ± 7.9

98.3 ± 5.4

UP780 (-)

2000

90.5 ± 4.2

113.7 ± 5.9

108.5 ± 4.0

95.1 ± 4.1

85.3 ± 3.3

Vehicle (+alloxan)

0

452.6 ± 18.9

518.0 ± 18.1

492.0 ± 22.6

486.1 ± 23.6

431.9 ± 21.2

Glyburide (+)

5

355.8 ± 21.6*

472.7 ± 28.2

438.5 ± 28.4

441.7 ± 35.1

398.7 ± 19.1

UP780 (+)

2000

289.9 ± 24.2*

382.9 ± 21.0*

331.2 ± 33.0*

339.7 ± 34.5*

315.1 ± 34.9*

UP394 (+)

80

400.2 ± 39.0

432.9 ± 33.0

483.4 ± 44.3

462.9 ± 47.5

442.1 ± 48.0

Qmatrix (+)

1920

374.7 ± 36.0

494.4 ± 32.0

447.5 ± 36.6

458.2 ± 43.0

443.2 ± 42.0

  1. Insulin dependent diabetes was induced by administering a single intraperitoneal injection of alloxan monohydrate at a dose of 150 mg/kg to CD-1 mice. Oral glucose tolerance test (OGTT) was conducted 4-week after onset of treatment. On the test day, animals (N = 15/group) were fasted for 5 hours and received oral administration of glucose at a dose of 2 g/kg. Blood glucose levels were determined at time 0 (before glucose injection), and at 30, 60, 90, and 120 minutes post glucose delivery. Blood samples were obtained from the tail. Data are expressed as mean ± SD. * P ≤ 0.05.